Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species

Cristina Russo, Enrico Tortoli, Donato Menichella

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The new commercial assay GenoType Mycobacterium, intended for the identification of mycobacteria, was evaluated with a panel of 197 strains belonging to 86 different taxa. The system, which relies on solid-phase reverse hybridization, is composed of two different kits: GenoType CM for the identification of more frequently detected mycobacterial species and GenoType AS for less common species. The sensitivity and specificity were 97.9% and 92.4% for the CM kit and 99.3% and 99.4% for the AS kit. Our results show that the system may represent a useful tool to substantially enlarge the number of mycobacteria that can be reliably identified in clinical laboratories.

Original languageEnglish
Pages (from-to)334-339
Number of pages6
JournalJournal of Clinical Microbiology
Volume44
Issue number2
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Mycobacterium
Genotype
Sensitivity and Specificity

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species. / Russo, Cristina; Tortoli, Enrico; Menichella, Donato.

In: Journal of Clinical Microbiology, Vol. 44, No. 2, 02.2006, p. 334-339.

Research output: Contribution to journalArticle

@article{221ee29b3b36461fb106784ffd7da2eb,
title = "Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species",
abstract = "The new commercial assay GenoType Mycobacterium, intended for the identification of mycobacteria, was evaluated with a panel of 197 strains belonging to 86 different taxa. The system, which relies on solid-phase reverse hybridization, is composed of two different kits: GenoType CM for the identification of more frequently detected mycobacterial species and GenoType AS for less common species. The sensitivity and specificity were 97.9{\%} and 92.4{\%} for the CM kit and 99.3{\%} and 99.4{\%} for the AS kit. Our results show that the system may represent a useful tool to substantially enlarge the number of mycobacteria that can be reliably identified in clinical laboratories.",
author = "Cristina Russo and Enrico Tortoli and Donato Menichella",
year = "2006",
month = "2",
doi = "10.1128/JCM.44.2.334-339.2006",
language = "English",
volume = "44",
pages = "334--339",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species

AU - Russo, Cristina

AU - Tortoli, Enrico

AU - Menichella, Donato

PY - 2006/2

Y1 - 2006/2

N2 - The new commercial assay GenoType Mycobacterium, intended for the identification of mycobacteria, was evaluated with a panel of 197 strains belonging to 86 different taxa. The system, which relies on solid-phase reverse hybridization, is composed of two different kits: GenoType CM for the identification of more frequently detected mycobacterial species and GenoType AS for less common species. The sensitivity and specificity were 97.9% and 92.4% for the CM kit and 99.3% and 99.4% for the AS kit. Our results show that the system may represent a useful tool to substantially enlarge the number of mycobacteria that can be reliably identified in clinical laboratories.

AB - The new commercial assay GenoType Mycobacterium, intended for the identification of mycobacteria, was evaluated with a panel of 197 strains belonging to 86 different taxa. The system, which relies on solid-phase reverse hybridization, is composed of two different kits: GenoType CM for the identification of more frequently detected mycobacterial species and GenoType AS for less common species. The sensitivity and specificity were 97.9% and 92.4% for the CM kit and 99.3% and 99.4% for the AS kit. Our results show that the system may represent a useful tool to substantially enlarge the number of mycobacteria that can be reliably identified in clinical laboratories.

UR - http://www.scopus.com/inward/record.url?scp=32344448560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32344448560&partnerID=8YFLogxK

U2 - 10.1128/JCM.44.2.334-339.2006

DO - 10.1128/JCM.44.2.334-339.2006

M3 - Article

VL - 44

SP - 334

EP - 339

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -